Related Experiment Video

Updated: Jul 3, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

An Overview on the Emerging Role of the Plasma Protease Inhibitor Protein ITIH5 as a Metastasis Suppressor

Krishnaveni Subramaniyam1, Sitaram Harihar2

  • 1Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 603203, Tamil Nadu, India.

Cell Biochemistry and Biophysics
|February 14, 2024
PubMed

Insights

Investigating metastasis suppressor genes offers new cancer treatment avenues. This review highlights the role of Inter-alpha-trypsin inhibitor heavy chain member 5 (ITIH5) in suppressing tumor metastasis, offering potential for clinical intervention.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Most cancers are diagnosed at advanced, malignant stages, often evading conventional treatments.
  • Metastasis suppressor genes represent a promising therapeutic strategy to inhibit tumor progression and spread.
  • Inter-alpha-trypsin inhibitor heavy chain member 5 (ITIH5) is emerging as a key player in cancer metastasis suppression.

Purpose of the Study:

  • To review the function of ITIH5 as a metastasis suppressor gene across various cancers.
  • To elucidate the mechanisms of action for ITIH5 in preventing cancer metastasis.
  • To explore the potential of ITIH5 as a therapeutic target for metastatic cancers.

Main Methods:

  • Literature review of existing studies on ITIH5 and cancer metastasis.
  • Analysis of data on ITIH5 expression and function in different cancer types.
  • Compilation of evidence regarding the anti-metastatic properties of ITIH5.

Main Results:

  • ITIH5 functions as a metastasis suppressor gene in multiple cancer types.
  • Evidence suggests ITIH5 actively inhibits tumor progression and metastasis.
  • The specific modes of action of ITIH5 are being elucidated through ongoing research.

Conclusions:

  • ITIH5 shows significant promise as an anti-metastatic protein.
  • Further research into ITIH5 could lead to novel clinical strategies for treating metastatic cancers.
  • Targeting ITIH5 may offer a new therapeutic approach to combat cancer spread.
Keywords:
Extracellular matrixITIH5MetastasisMetastasis suppressor genesSerine proteaseTumor

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.2K
Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.0K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K